These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3866270)

  • 1. [In vitro antimicrobial activity of CI-919 against gram-negative bacilli and Staphylococcus aureus isolated from various pathologies].
    Prado V; Reyes L
    Rev Med Chil; 1985 Feb; 113(2):94-102. PubMed ID: 3866270
    [No Abstract]   [Full Text] [Related]  

  • 2. Antimicrobial resistance among gram-negative bacilli to newer aminoglycosides and beta-lactams.
    Jain S; Sarkar R
    Indian J Pathol Microbiol; 1991 Oct; 34(4):280-7. PubMed ID: 1818033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mechanisms of antimicrobial resistance].
    Hori S; Hiramatsu K
    Nihon Rinsho; 1994 Feb; 52(2):327-31. PubMed ID: 8126881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Enoxacin and ciprofloxacin: in vitro effect on Enterobacteriaceae, Pseudomonas aeruginosa and Staphylococcus aureus].
    Roy C; Foz A; Segura C; Tirado M; Teixell M; Teruel D
    Med Clin (Barc); 1986 Jan; 86(1):1-3. PubMed ID: 2937983
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibacterial activity of enoxacin: comparison with aminoglycosides, beta-lactams and other antimicrobial agents.
    Vanhoof R; Hubrechts JM; Roebben E; Claeys M; Nyssen HJ
    J Antimicrob Chemother; 1986 Mar; 17(3):297-302. PubMed ID: 3457785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bacteremias in a university hospital: study of etiologic agents and their sensitivity patterns].
    Betriu C; Palau L; Gómez M; Sánchez A; Romero J; Picazo JJ
    Rev Clin Esp; 1999 Aug; 199(8):503-10. PubMed ID: 10522430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro activity of enoxacin against aminoglycoside-resistant gram-negative bacilli and other clinical isolates.
    Duncan IB; Skulnick M; Marshall PW
    J Antimicrob Chemother; 1984 Sep; 14 Suppl C():1-6. PubMed ID: 6438046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of CI-934 and other antimicrobial agents against gram-positive and gram-negative bacteria.
    Smith RP; Baltch AL; Hammer MC; Conroy JV
    Clin Ther; 1986; 9(1):106-18. PubMed ID: 3815456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of imipenem and six other beta-lactam antibiotics against aminoglycoside resistant gram-negative bacilli.
    Bujdáková H; Kallová J; Lausová A; Kettner M
    Microbios; 1995; 84(339):87-90. PubMed ID: 8628124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro antibacterial activity of enoxacin, a new pyridonecarboxylic acid.
    Fabio U; Bondi M; Galletti F; Manicardi G; Messi P; Neglia R; Casolari C
    Boll Ist Sieroter Milan; 1987; 66(2):110-5. PubMed ID: 3478050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sensitivity to aminoglycosides and cephalosporins of staphylococci and gram-negative bacteria isolated from patients hospitalized in Wrocław clinics (1985)].
    Grzybek-Hryncewicz K; Ruczkowska-Struzik J
    Przegl Lek; 1987; 44(3):315-8. PubMed ID: 3615936
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro activity of Ro 17-2301, a new monobactam, against gram-negative bacteria resistant to aminoglycosides.
    Landinez R; Garcia M; Merino C
    Chemioterapia; 1987 Jun; 6(2 Suppl):112-4. PubMed ID: 3509365
    [No Abstract]   [Full Text] [Related]  

  • 13. [Non-fermentative Gram-negative bacilli of human origin. II. In vitro sensitivity of 185 strains to 17 anti-microbial agents].
    Paredes L; Thompson L; del Canto E; Paredes L
    Rev Med Chil; 1985 Sep; 113(9):878-85. PubMed ID: 3837315
    [No Abstract]   [Full Text] [Related]  

  • 14. In vitro activity of isepamicin and other aminoglycosides against clinical isolates of Gram-negative bacteria causing nosocomial bloodstream infections.
    Tsai TY; Chang SC; Hsueh PR; Feng NH; Wang JT
    J Microbiol Immunol Infect; 2007 Dec; 40(6):481-6. PubMed ID: 18087627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial activity of some heterocyclic derivatives.
    Alsaleh FS; Gamal el-Din AY; Kandeel EM
    Microbios; 1995; 82(331):87-93. PubMed ID: 7609663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative in vitro activity of eight antibiotics against Pseudomonas aeruginosa and infrequently isolated gram-negative bacilli.
    Chiaradia V; Pascoli L; Santini G
    Chemioterapia; 1985 Aug; 4(4):284-8. PubMed ID: 3931923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergic activity of beta-lactamines and aminoglycosides vs. bacterial strains treated with sub-MIC concentrations.
    Gismondo MR; Romeo MA; Pappalardo C; Puglisi G; Leonardi R
    Chemioterapia; 1984 Jun; 3(3):175-7. PubMed ID: 6529773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Distribution of pathogen and resistance of nosocomial infections in the intensive care units].
    Dai CM; Zhou JD; Wu Y; Qi Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Apr; 31(2):277-80. PubMed ID: 16706133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro antimicrobial activity of telavancin against methicillin-resistant Staphylococcus aureus clinical isolates from Japan (2006).
    Hatano K; Matsuzaki K; Sato Y; Kobayashi I; Yamaguchi K
    J Antibiot (Tokyo); 2007 Nov; 60(11):709-12. PubMed ID: 18057701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Aminoglycoside activity in relation to gram-negative microflora isolated from heart surgery patients].
    Ostrovskaia EA; Khaimova MD
    Antibiotiki; 1983 Sep; 28(9):693-8. PubMed ID: 6638983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.